BRPI0411400A - processo para a produção de extratos e usos de caralluma - Google Patents

processo para a produção de extratos e usos de caralluma

Info

Publication number
BRPI0411400A
BRPI0411400A BRPI0411400-0A BRPI0411400A BRPI0411400A BR PI0411400 A BRPI0411400 A BR PI0411400A BR PI0411400 A BRPI0411400 A BR PI0411400A BR PI0411400 A BRPI0411400 A BR PI0411400A
Authority
BR
Brazil
Prior art keywords
caralluma
extract
production
extracts
exceed
Prior art date
Application number
BRPI0411400-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Ramaswamy Rajendran
Kamala Rajendran
Original Assignee
Ramaswamy Rajendran
Kamala Rajendran
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ramaswamy Rajendran, Kamala Rajendran filed Critical Ramaswamy Rajendran
Publication of BRPI0411400A publication Critical patent/BRPI0411400A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/27Asclepiadaceae (Milkweed family), e.g. hoya
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
BRPI0411400-0A 2003-06-04 2004-05-31 processo para a produção de extratos e usos de caralluma BRPI0411400A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN451CH2003 2003-06-04
PCT/IN2004/000150 WO2004108148A1 (en) 2003-06-04 2004-05-31 Processes for making caralluma extracts and uses

Publications (1)

Publication Number Publication Date
BRPI0411400A true BRPI0411400A (pt) 2006-07-25

Family

ID=36011983

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411400-0A BRPI0411400A (pt) 2003-06-04 2004-05-31 processo para a produção de extratos e usos de caralluma

Country Status (12)

Country Link
US (2) US7060308B2 (enExample)
EP (1) EP1644013A1 (enExample)
JP (2) JP5260873B2 (enExample)
KR (2) KR20060034229A (enExample)
CN (1) CN1798566B (enExample)
AU (2) AU2004244850B2 (enExample)
BR (1) BRPI0411400A (enExample)
CA (1) CA2527702C (enExample)
CO (1) CO5660269A2 (enExample)
NZ (2) NZ543995A (enExample)
WO (1) WO2004108148A1 (enExample)
ZA (1) ZA200509780B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060083795A1 (en) * 2004-10-19 2006-04-20 Lima Shatkina Meal replacement products having appetite suppressing qualities
KR101307999B1 (ko) * 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
US20060159773A1 (en) * 2005-01-20 2006-07-20 Stephen Holt Herbal compositions containing hoodia
WO2007022141A1 (en) * 2005-08-17 2007-02-22 Charles Tadlock Delivery system for appetite suppressant
CN101505771A (zh) * 2006-08-17 2009-08-12 荷兰联合利华有限公司 含有甾体糖苷的hoodia植物萃取物的制造方法
WO2008107910A2 (en) * 2007-03-05 2008-09-12 Ramaswamy Rajendran Use of caralluma extracts in the inhibition of adipogenesis and a method of inhibition for the same
ZA201000727B (en) * 2009-01-30 2010-11-24 Vishwas Sudhu Ghare An improved process for the preparation of caralluma extract and a formulation prepared thereof
US20130122146A1 (en) * 2011-11-16 2013-05-16 Decas Botanical Synergies, Llc Process for Spray Drying Botanical Food
US9456916B2 (en) 2013-03-12 2016-10-04 Medibotics Llc Device for selectively reducing absorption of unhealthy food
US9011365B2 (en) 2013-03-12 2015-04-21 Medibotics Llc Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food
US9067070B2 (en) 2013-03-12 2015-06-30 Medibotics Llc Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type
TWI687223B (zh) 2013-04-30 2020-03-11 日商日本臟器製藥股份有限公司 萃取物及含有該萃取物的製劑
EP2810565A1 (en) * 2013-06-03 2014-12-10 Dupont Nutrition Biosciences ApS Antioxidant composition
CN103969393A (zh) * 2014-04-25 2014-08-06 上海相宜本草化妆品股份有限公司 用于化妆品中糖苷类中草药化合物含量测试的前处理方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960839A (en) * 1973-02-09 1976-06-01 Escuela Politecnica Nacional Process for recovering and isolating solasodine and glycosides thereof
US5270457A (en) * 1992-06-12 1993-12-14 University Of Manitoba Cardiac steriod glycosides
ATE502041T1 (de) 1997-04-15 2011-04-15 Csir Nicht-therapeutische methode zur appetitunterdrückung
EP0931550B1 (en) * 1998-01-26 2004-09-22 National Research Development Corporation, a Government of India Undertaking A process for the preparation of a spermicidal agent
US6703051B1 (en) 1998-10-13 2004-03-09 Solae, Llc Process for separating and recovering protein and isoflavones from a plant material
US6124442A (en) * 1999-03-24 2000-09-26 Zhou; James H. Process for extracting triterpene glycosides from botanical sources
US6224906B1 (en) * 1999-08-31 2001-05-01 Natreon Inc. St. John's wort composition
US6635758B2 (en) * 2000-09-25 2003-10-21 Industrial Technology Research Institute Process for extracting glycoside using an aqueous two-phase system
EP1994837A3 (en) * 2001-11-16 2009-11-11 Nestec S.A. Plant derived or derivable material with appetite suppressant activity

Also Published As

Publication number Publication date
US7060308B2 (en) 2006-06-13
CN1798566B (zh) 2014-03-12
AU2004244850A1 (en) 2004-12-16
NZ543995A (en) 2009-02-28
NZ573614A (en) 2011-02-25
KR20060034229A (ko) 2006-04-21
JP2013067638A (ja) 2013-04-18
JP2006526615A (ja) 2006-11-24
CA2527702C (en) 2016-03-08
AU2004244850B2 (en) 2009-01-08
WO2004108148A1 (en) 2004-12-16
KR20070114833A (ko) 2007-12-04
AU2008255233B2 (en) 2012-01-12
CA2527702A1 (en) 2004-12-16
JP5260873B2 (ja) 2013-08-14
US7390516B2 (en) 2008-06-24
US20040247702A1 (en) 2004-12-09
ZA200509780B (en) 2006-09-27
EP1644013A1 (en) 2006-04-12
KR100993487B1 (ko) 2010-11-10
CN1798566A (zh) 2006-07-05
US20050163871A1 (en) 2005-07-28
AU2008255233A1 (en) 2009-01-22
AU2004244850A2 (en) 2004-12-16
CO5660269A2 (es) 2006-07-31

Similar Documents

Publication Publication Date Title
BRPI0411400A (pt) processo para a produção de extratos e usos de caralluma
Ademosun et al. Anticholinesterase and antioxidative properties of water-extractable phytochemicals from some citrus peels
Suica-Bunghez et al. Antioxidant activity and phytochemical compounds of snake fruit (Salacca Zalacca)
Russo et al. phenolic fractions on platelet aggregation
Mahasuari et al. Effect of methanol concentration as a solvent on total phenolic and flavonoid content of beluntas leaf extract (pulchea indica l.)
BRPI0409523A (pt) método para o tratamento da dor neuropática, método de identificação de um composto e composição farmacêutica
BR0103844A (pt) Sistema de aditivo polimérico múltiplo, processo para produzir o mesmo, composição polimérica, e, processo para produzir a mesma
Lecci et al. Antioxidant and pro-oxidant capacities as mechanisms of photoprotection of olive polyphenols on UVA-damaged human keratinocytes
DE3767849D1 (de) Arzneimittel zur vorbeugung und behandlung der alkoholischen toxicomanie und verfahren zu ihrer herstellung.
ES2148813T3 (es) Procedimiento para la elaboracion de plantas que contienen proteinas.
PT1648566E (pt) Processo para a preparação de composições contendo flavonóides e sua utilização
Nafti et al. Variability of phenolic compounds and antioxidant efficacy in needles extracts of Pinus nigra Arn
BR0313258A (pt) Composição de tomate obtida a partir de suco de tomate ou extratos de tomate, uso da mesma, alimentos, e, processo para a separação do lìquido (soro de suco de tomate) de uma suspensão de tomate
Kalaiselvi et al. Occurrence of Bioactive compounds in Ananus comosus (L.): A quality Standardization by HPTLC
BR0103842A (pt) Sistema de aditivo lìquido-sólido funcional, processo para produzir o mesmo, composição polimérica, e, processo para produzir a mesma
Touaibia et al. Anti-inflammatory effect of Myrtus nivellei Batt & Trab (Myrtaceae) methanolic extract
Moshfegh et al. Neuroprotective Effect of Matricaria chamomilla Extract on Motor Dysfunction Induced by Transient Global Cerebral Ischemia and Reperfusion in Rat.
Essien et al. Phytochemical and anti nutrient evaluation of some wild fruiting polypore microfungi
Raju et al. Depletion of vitamin-C and glutathione by acrylamide causes damage to hippocampus region of brain in chick embryo
Suhail Comparative evaluation of antioxidant activity of methanolic extract of Saraca asoca and its commonly used substitute plants
Pandy et al. In vitro acetylcholinesterase inhibitory activity of different capsicum varieties by using chicken brain extract prepared by employing a home mixer-jar as an alternative to expensive tissue homogenizer
Maleš et al. Quantitative analysis of phenolic compounds of Inula candida (L.) Cass.
Naseeb et al. Evaluation of antivenom activity of ethanolic extract of Buchanania lanzan bark against Naja kaouthia snake venom
RU2563616C1 (ru) Способ увеличения степени извлечения экдистероидов и флавоноидов из растительных объектов
Khalid et al. Phytopharmacological assessment of some medicinal plants of Thal desert of Pakistan

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE A61K 35/78

Ipc: A61K 36/27 (2006.01)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 13, 10 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.